We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Shihchen Kuo

Shihchen Kuo RPh PhD

Assistant Research Scientist, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

Dr. Shihchen Kuo is a pharmacist, a PhD-trained epidemiologist and decision-analytic modeler, and an Assistant Research Scientist in the Division of Metabolism, Endocrinology & Diabetes in the Department of Internal Medicine at the University of Michigan Medical School. Dr. Kuo received his PhD in Epidemiology from the University of Pittsburgh Graduate School of Public Health, with a concentration in diabetes and translational epidemiology, comparative effectiveness research, clinical economics and decision analysis, and computational simulation modeling. He completed his postdoctoral fellowship training with Dr. William Herman and his team in the modeling core of the Michigan Center for Diabetes Translational Research at the University of Michigan. The focus of Dr. Kuo’s research is identifying innovative and scalable approaches to help healthcare professionals and policymakers make sound decisions about diabetes care, primarily by leveraging insights from clinical economics and decision-analytic sciences. Specifically, his research focuses on enhancing diabetes prevention and control, with an emphasis on the application of clinical epidemiology and economics, decision-analytic sciences, and computational simulation modeling from the healthcare sector and societal perspectives, to simulate disease progression and explore cost-effective strategies for diabetes management.

Recent Contributions to PracticeUpdate:

  1. Estimated Lifetime Economic Burden of Type 1 Diabetes